Newborn screening in Taiwan: Q&A with Dr Yin-Hsiu (Nancy) Chien

C.Yin-HsiuC.Yin-Hsiu
BulletArticle
Newborn Screening Rare Diseases
공유:
링크 복사
Newborn screening in Taiwan: Q&A with Dr Yin-Hsiu (Nancy) Chien

As Director of the Newborn Screening Centre at National Taiwan University Hospital, Dr Yin-Hsiu (Nancy) Chien is at the forefront of Taiwan’s newborn screening (NBS) efforts. In this Q&A, we speak with Dr Chien about how NBS works in Taiwan, drawing upon her experience as a clinician-researcher and lab director to explore key considerations around panel composition, sample collection, lab workflows, and hopes for the future of NBS.

공유:
링크 복사

동일한 주제에 대한 추가 정보

Should newborn screening include chromosome 15q disorders?

How Early Check shapes newborn screening policy with better evidence

권장 주제

SequencingRED 2020Rare Diseases
다음 읽기
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top